Antithymocyte Globulin and Cyclosporine in Treating Low Risk Patients With Myelodysplastic Syndrome

Clinical trial NCT00488436 · COMPLETED

Trial details

NCT number: NCT00488436
Sponsor: PETHEMA Foundation
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Myelodysplastic Syndrome

Start date: 2002-05-01
Primary completion: 2007-06-01
Enrollment: 25

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.